| 37.995 0.065 (0.17%) | 04-28 11:18 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 48.3 | 1-year : | 56.42 |
| Resists | First : | 41.36 | Second : | 48.3 |
| Pivot price | 37.91  |
|||
| Supports | First : | 36.76 | Second : | 33.91 |
| MAs | MA(5) : | 37.32 |
MA(20) : | 37.98 |
| MA(100) : | 33.22 |
MA(250) : | 27.98 |
|
| MACD | MACD : | 0.4 |
Signal : | 0.6 |
| %K %D | K(14,3) : | 38.6 |
D(3) : | 31.5 |
| RSI | RSI(14): 55.3 |
|||
| 52-week | High : | 41.36 | Low : | 19.17 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ GRDN ] has closed above bottom band by 49.9%. Bollinger Bands are 22.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 39.61 - 39.75 | 39.75 - 39.88 |
| Low: | 37.52 - 37.69 | 37.69 - 37.85 |
| Close: | 37.66 - 37.9 | 37.9 - 38.12 |
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.
Mon, 27 Apr 2026
BofA initiates Guardian Pharmacy Services stock with buy rating - Investing.com
Sun, 26 Apr 2026
Truist Securities Maintains Guardian Pharmacy Services (GRDN) Buy Recommendation - MSN
Sat, 25 Apr 2026
Guardian Pharmacy Services (GRDN) price target increased by 10.00% to 39.27 - MSN
Sat, 25 Apr 2026
Wall Street Zen Upgrades Guardian Pharmacy Services (NYSE:GRDN) to Strong-Buy - MarketBeat
Thu, 23 Apr 2026
Guardian Pharmacy CEO to speak in Las Vegas; webcast open to public - Stock Titan
Fri, 17 Apr 2026
Is It Too Late To Revisit Guardian Pharmacy Services (GRDN) After Its 53% One Year Surge? - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 37 (M) |
| Shares Float | 19 (M) |
| Held by Insiders | 51.4 (%) |
| Held by Institutions | 57.7 (%) |
| Shares Short | 2,910 (K) |
| Shares Short P.Month | 1,790 (K) |
| EPS | 0.77 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.25 |
| Profit Margin | 3.4 % |
| Operating Margin | 8.8 % |
| Return on Assets (ttm) | 13.6 % |
| Return on Equity (ttm) | 26.6 % |
| Qtrly Rev. Growth | 17.3 % |
| Gross Profit (p.s.) | 7.85 |
| Sales Per Share | 38.89 |
| EBITDA (p.s.) | 2.75 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 100 (M) |
| Levered Free Cash Flow | 74 (M) |
| PE Ratio | 48.6 |
| PEG Ratio | 0 |
| Price to Book value | 11.66 |
| Price to Sales | 0.97 |
| Price to Cash Flow | 14.09 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|